Medication Assisted Treatment Waiver Training for APRNs
Free, Online & With New Nursing Content!
Medication Assisted Treatment Waiver Training for Nurses
8 Hour Training + 16 Hour Training =
24 Hours of Education Required to Obtain a MAT Waiver
Register now for these 2 FREE courses on medication assisted treatment (MAT) for opioid use disorders and:
- Complete the required 24 hours of education required to obtain a DEA waiver to prescribe MAT (including buprenorphine) for opioid use disorders.
- Earn 24 CE contact hours, 21 of which are in pharmacology
- Get a solid foundation in practices to decrease opioid use and opioid related deaths.
- Explore issues you might encounter when assessing and providing MAT to persons with opioid use disorders.
- Understand how current regulations affect your role and responsibilities as a provider.
|Learn More & Register|
Note that these are two standalone courses which will each come with a CE certificate. Instructions for obtaining a DEA waiver will be sent upon completion of the 24 hours of training.
(August 24, 2017) Clarification received from SAMHSA:
Nurse practitioners and physician assistants may use their waiver to prescribe buprenorphine products for the treatment of opioid use disorder in any healthcare setting including OTPs. However, the healthcare setting or employer, OTP or otherwise, is free to establish by policy which services are to be provided and by which professionals. Any practitioner who uses the waiver to treat patients must comply with their patient limit regardless of the treatment setting. Nurse practitioners and physician assistants may order buprenorphine or methadone for administration or dispensing from an OTP without a DATA waiver, but must receive an exemption from SAMHSA to make dose and administration adjustments.
(May 19, 2017) Here are updates to the three aspects of the MAT waiver process for APRNs: the required 24 hours of education, the process for issuing MAT waivers, and the regulations for implementing the CARA 2016 legislation.
- Educational Content for Required Training
PCSS-MAT waiver training coursework has been released. Access the course here free of charge.
- OMB Approval of MAT Waiver Issuance Process
From SAMHSA Website as of February 28, 2017:
NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI. NPs and PAs may send copies of their training certificates to firstname.lastname@example.org or faxed them to 301-576-5237.
These waiver applications will be forwarded to the DEA, which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number. SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number.
- HHS Regulation to Implement CARA 2016
No further HHS regulation is needed before eligible NPs or PAs with a properly authorized wavier can begin prescribing buprenorphine, subject to applicable statutory patient limits.